NDTP
Price:
$0.99
Market Cap:
$158.40M
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.
Industry
Biotechnology
IPO Date
2008-01-22
Stock Exchange
OTC
Ticker
NDTP
According to NDT Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -20.34%. This represents a change of 616.23% compared to the average of -2.84% of the last 4 quarters.
The mean historical ROE of NDT Pharmaceuticals Inc. over the last ten years is 675.49%. The current -20.34% ROE has changed -103.01% with respect to the historical average. Over the past ten years (40 quarters), NDTP's ROE was at its highest in in the December 2007 quarter at 6.35%. The ROE was at its lowest in in the March 2007 quarter at -210.88%.
Average
675.49%
Median
0.51%
Minimum
-178.90%
Maximum
6.59%
Discovering the peaks and valleys of NDT Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 6.59%
Minimum Annual Increase = -19564.35%
Minimum Annual ROE = -178.90%
| Year | ROE | Change |
|---|---|---|
| 2024 | 0% | -100.00% |
| 2023 | -78.12% | -19564.35% |
| 2017 | 0.40% | -35.98% |
| 2016 | 0.63% | -97.81% |
| 2015 | 28.67% | -76.24% |
| 2014 | 120.66% | -65.27% |
| 2010 | 347.44% | -94.73% |
| 2007 | 6.59% | -8816.47% |
| 2006 | -75.60% | -57.74% |
The current ROE of NDT Pharmaceuticals Inc. (NDTP) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-25.91%
5-year avg
-9.68%
10-year avg
675.49%
NDT Pharmaceuticals Inc.’s ROE is greater than Botanix Pharmaceuticals Limited (-99.43%), greater than Innate Pharma S.A. (-658.91%), greater than Molecular Partners AG (-50.31%), less than Scancell Holdings plc (126.94%), greater than Brii Biosciences Limited (-14.61%), greater than JW (Cayman) Therapeutics Co. Ltd (-59.45%), greater than Hofseth BioCare ASA (-279.05%), greater than Ascend Wellness Holdings, Inc. (-225.92%), greater than NervGen Pharma Corp. (-879.68%), less than Kintor Pharmaceutical Limited (0%),
| Company | ROE | Market cap |
|---|---|---|
| -99.43% | $150.41M | |
| -658.91% | $183.43M | |
| -50.31% | $134.64M | |
| 126.94% | $140.10M | |
| -14.61% | $173.42M | |
| -59.45% | $150.63M | |
| -279.05% | $66.68M | |
| -225.92% | $125.92M | |
| -879.68% | $332.96M | |
| 0% | $94.90M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NDT Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NDT Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NDT Pharmaceuticals Inc.'s ROE?
How is the ROE calculated for NDT Pharmaceuticals Inc. (NDTP)?
What is the highest ROE for NDT Pharmaceuticals Inc. (NDTP)?
What is the 3-year average ROE for NDT Pharmaceuticals Inc. (NDTP)?
What is the 5-year average ROE for NDT Pharmaceuticals Inc. (NDTP)?
How does the current ROE for NDT Pharmaceuticals Inc. (NDTP) compare to its historical average?